The global forage feed market has been undergoing noteworthy development in the past few years. This can be accredited to the progression in farm animal production, upsurge in the global meat intake, and growing awareness regar…
BMI View: The Argentinean pharmaceutical market will continue to experience downward pressure owing
to a contraction in consumption indices in the near term. In the long term, however, market growth
fundamentals will remain robust, creating commercial and investment opportunities for drugmakers. While
the expected introduction of a national HTA agency over the coming quarters could create a new market
access hurdle, the importance of value-adding innovative therapies will continue to be recognised by health
sector stakeholders owing to the robust scientific and medical culture in the country.
Headline Expenditure Projections
Pharmaceuticals: ARS64.02bn (USD6.91bn) in 2015 to ARS79.31bn (USD5.57bn) in 2016; +23.9% in
local currency terms and -19.5% in US dollar terms. Forecast unchanged in local currency terms and
revised slightly upwards in US dollar terms from last quarter.
Healthcare: ARS250.68bn (USD27.06bn) in 2015 to ARS319.01bn (USD22.39bn) in 2016; +27.3% in
local currency terms and -17.3% in US dollar terms. Forecast revised upwards from last quarter.